June 5, 2007 - Photon2 announced that it has received FDA approval for its new compact cardiac camera. The C! is a gamma camera designed for cardiologists in the diagnosis of cardiac disease.
June 5, 2007 — Men whose blood tests positive for the auto-antibody rheumatoid factor have a three times higher risk of ...
June 5, 2007 - Siemens Medical Solutions Molecular Imaging division demonstrated three new syngo software packages ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 4, 2007 — Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AspirinWorks Test Kit, the Company's newest diagnostic product.
June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.
June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 4, 2007 — A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and ...
June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional ...
June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.
June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was ...
May 31, 2007 — MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI). The total blockage of a coronary artery is fatal unless treated quickly — within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.
May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of ...
May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent ...